德尔塔
您当前所在位置:首页 > 定制产品 > 热销推荐
CAS:107632-22-4|Phosphate dibasic-d1 sodium,磷酸氢二钠 无水-d1; Exsiccated sodium phosphate-d1

CAS:107632-22-4|Phosphate dibasic-d1 sodium,磷酸氢二钠 无水-d1; Exsiccated sodium phosphate-d1

作者:德尔塔生物 日期:2025-07-08

生物活性:Phosphate dibasic-d2 (sodium) is the deuterium labeled Sodium phosphate dibasic[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:142.97Formula:DNa2O4PCAS 号:107632-22-4性状:固体颜色:White to off-white中文名称:磷酸氢二钠-d1运输条件:Room temperature in continental US; may vary elsewhere.储存方式:4°C, sealed storage, away from moisture*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)纯度 & 产品资料纯度: ≥99.0%参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

CAS:154492-74-7|Phenoxyacetic acid-d5

CAS:154492-74-7|Phenoxyacetic acid-d5

作者:德尔塔生物 日期:2025-07-08

生物活性:Phenoxyacetic acid-d5 is the deuterium labeled Phenoxyacetic acid[1]. Phenoxyacetic acid is an endogenous metabolite.体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Phenoxyacetic acid-d5 相关抗体:BNSP AntibodyFACL4 AntibodyBrdU Antibody (YA578)GAPDH AntibodyGlucose 6 Phosphate Dehydrogenase AntibodyMETTL3 AntibodyTSG101 AntibodyAlkaline Phosphatase AntibodyCalnexin Antibody (YA573)Lamin A/C AntibodyLamin B1 AntibodyLAMP1 AntibodyLAMP2 Antibody (YA713)LAMP2a AntibodyNQO1 Antibody (YA697)NQO1 Antibody (YA261)OPA1 AntibodyRBM3 AntibodySynaptophysin Antibody (YA043)Laminin beta 1 AntibodyHeme Oxygenase 1 AntibodyKi67 Antibody (YA717)Ki67 Antibody (YA322)Asparagine Synthetase AntibodyCalnexin AntibodyKi67 Antibody (YA001)Osteopontin AntibodySynaptophysin Antibody (YA664)TREM2 AntibodyGAPDH Antibody (YA848)分子量:157.18Formula:C8H3D5O3CAS 号:154492-74-7性状:固体颜色:White to off-white运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:146672-02-8|4-Hydroxybenzoic acid-13C,对羟基苯甲酸-13C

CAS:146672-02-8|4-Hydroxybenzoic acid-13C,对羟基苯甲酸-13C

作者:德尔塔生物 日期:2025-07-08

生物活性:4-Hydroxybenzoic acid-13C is the 13C labeled 4-Hydroxybenzoic acid[1]. 4-Hydroxybenzoic acid, a phenolic derivative of benzoic acid, could inhibit most gram-positive and some gram-negative bacteria, with an IC50 of 160 μg/mL[2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.4-Hydroxybenzoic acid-13C 相关抗体:BNSP AntibodyFACL4 AntibodyBrdU Antibody (YA578)GAPDH AntibodyGlucose 6 Phosphate Dehydrogenase AntibodyMETTL3 AntibodyTSG101 AntibodyAlkaline Phosphatase AntibodyCalnexin Antibody (YA573)Lamin A/C AntibodyLamin B1 AntibodyLAMP1 AntibodyLAMP2 Antibody (YA713)LAMP2a AntibodyNQO1 Antibody (YA697)NQO1 Antibody (YA261)OPA1 AntibodyRBM3 AntibodySynaptophysin Antibody (YA043)Laminin beta 1 AntibodyHeme Oxygenase 1 AntibodyKi67 Antibody (YA717)Ki67 Antibody (YA322)Asparagine Synthetase AntibodyCalnexin AntibodyKi67 Antibody (YA001)Osteopontin AntibodySynaptophysin Antibody (YA664)TREM2 AntibodyGAPDH Antibody (YA848)分子量:139.11Formula:C613CH6O3CAS 号:146672-02-8性状:固体颜色:White to off-white中文名称:对羟基苯甲酸-13C; 4-羟基苯甲酸-13C运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month纯

CAS:32190-42-4|2,2′-Bipyridine-d8,2,2'-Dipyridyl-d8

CAS:32190-42-4|2,2′-Bipyridine-d8,2,2'-Dipyridyl-d8

作者:德尔塔生物 日期:2025-07-08

生物活性:2,2′-Bipyridine-d8 is the deuterium labeled 2,2′-Bipyridine-d8[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:164.23Formula:C10D8N2CAS 号:32190-42-4非标记 CAS:366-18-7性状:固体颜色:White to off-white中文名称:2,2′-二吡啶-d8运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:52921-77-4|1,3,5-Tribromobenzene-d3,1,3,5-三溴苯-d3

CAS:52921-77-4|1,3,5-Tribromobenzene-d3,1,3,5-三溴苯-d3

作者:德尔塔生物 日期:2025-07-08

生物活性:1,3,5-Tribromobenzene-d3 is the deuterium labeled 1,3,5-Tribromobenzene[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:317.82Formula:C6D3Br3CAS 号:52921-77-4性状:固体颜色:White to off-white中文名称:1,3,5-三溴苯-d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month纯度 & 产品资料Data Sheet (524 KB)产品使用指南 (1538 KB)参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

CAS:328946-18-5|1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22

CAS:328946-18-5|1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22

作者:德尔塔生物 日期:2025-07-08

生物活性:1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22 is deuterium labeled 1,2-Dihexanoyl-sn-glycero-3-phosphocholine.体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:475.64Formula:C20H18D22NO8PCAS 号:328946-18-5性状:固体颜色:White to off-white运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:1131345-14-6|Etoricoxib-d4,依托考昔 D4; MK-0663-d4; L-791456-d4

CAS:1131345-14-6|Etoricoxib-d4,依托考昔 D4; MK-0663-d4; L-791456-d4

作者:德尔塔生物 日期:2025-07-08

生物活性:Etoricoxib-d4 is a deuterium labeled Etoricoxib. Etoricoxib is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood.分子量:362.87Formula:C18H11D4ClN2O2SCAS 号:1131345-14-6非标记 CAS:202409-33-4性状:固体颜色:Light yellow to yellow中文名称:依托考昔 d4运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:2 years-20°C:1 year

CAS:1564242-30-3|Baricitinib-d3,LY3009104-d3; INCB028050-d3

CAS:1564242-30-3|Baricitinib-d3,LY3009104-d3; INCB028050-d3

作者:德尔塔生物 日期:2025-07-08

生物活性:Baricitinib-d3 is the deuterium labeled Baricitinib. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Baricitinib-d3 相关抗体:Phospho-JAK2 (Tyr1007/1008) AntibodyJAK1 Antibody (YA722)JAK1 AntibodyJAK2 Antibody (YA721)Phospho-JAK2 (Tyr1007+Tyr1008) AntibodyJAK2 Antibody (YA330)Phospho-JNK (Thr183) AntibodyJAK3 Antibody (YA2466)分子量:374.44Formula:C16H14D3N7O2SCAS 号:1564242-30-3非标记 CAS:1187594-09-7性状:固体颜色:White to off-white中文名称:巴瑞克替尼 d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month纯度 & 产品资料纯度: ≥99.0%参考文献[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.  [Content Brief][2]. Fridman JS, et al. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol. 2010 May 1;184(9):5298-307. [Content Brief][3]. Jabbari A, et al. Reversal of Alopecia Areata Following Treatmen

CAS:1256490-42-2|PSI-6206-13C,d3,RO-2433-13C,d3; GS-331007-13C,d3; Sofosbuvir metabolite GS-331007-13C,d3

CAS:1256490-42-2|PSI-6206-13C,d3,RO-2433-13C,d3; GS-331007-13C,d3; Sofosbuvir metabolite GS-331007-13C,d3

作者:德尔塔生物 日期:2025-07-08

生物活性:PSI-6206-13C,d3 is the deuterium labeled PSI-6206. PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.分子量:264.23Formula:C913CH10D3FN2O5CAS 号:1256490-42-2非标记 CAS:863329-66-2性状:固体颜色:White to light yellow运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:1217709-85-7|Repaglinide-d5,瑞格列奈 D5; AG-EE 623ZW d5

CAS:1217709-85-7|Repaglinide-d5,瑞格列奈 D5; AG-EE 623ZW d5

作者:德尔塔生物 日期:2025-07-08

生物活性:Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].体外研究(In Vitro):Repaglinide reduces postprandial glucose levels by enhancing the early phase of insulin secretion and increasing the total amount of insulin secreted[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Repaglinide-d5 相关抗体:ATP1A1 AntibodyLGI1 Antibody (YA2885)Cardiac Troponin C Antibody (YA2125)Cardiac Troponin T Antibody (YA2719)SAP97 Antibody (YA2731)Kir2.1 Antibody (YA2871)分子量:457.62Formula:C27H31D5N2O4CAS 号:1217709-85-7非标记 CAS:135062-02-1性状:固体颜色:White to off-white中文名称:瑞格列奈 d5运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:958293-79-3|(±-Naproxen-d3,(Rac-Naproxen-d3

CAS:958293-79-3|(±-Naproxen-d3,(Rac-Naproxen-d3

作者:德尔塔生物 日期:2025-07-08

生物活性:(±)-Naproxen-d3 is the deuterium labeled (±)-Naproxen. (±)-Naproxen is a non-steroidal anti-inflammatory drug (NSAID)[1].分子量:233.28Formula:C14H11D3O3CAS 号:958293-79-3非标记 CAS:23981-80-8性状:固体颜色:Off-white to light yellow中文名称:萘普生 d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:2135309-51-0|IDH1 Inhibitor 7-d2

CAS:2135309-51-0|IDH1 Inhibitor 7-d2

作者:德尔塔生物 日期:2025-07-08

生物活性:IDH1 Inhibitor 7-d2 is the deuterium labeled IDH1 Inhibitor 7 (HY-150238). IDH1 Inhibitor 7 is an IDH1 inhibitor with an IC50 of less than 100 nM[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.IDH1 Inhibitor 7-d2 相关抗体:IDH1 AntibodyAconitase 2 Antibody (YA2151)Aconitase 1 Antibody (YA2850)分子量:461.48Formula:C22H22D2F3N7OCAS 号:2135309-51-0非标记 CAS:2135309-56-5性状:固体颜色:White to off-white运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:1265295-21-3|Selexipag-d7

CAS:1265295-21-3|Selexipag-d7

作者:德尔塔生物 日期:2025-07-08

生物活性:Selexipag-d7 is the deuterium labeled Selexipag. Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor)[1][2].IC50 & Target:IP体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Selexipag-d7 相关抗体:Prostaglandin D Synthase Antibody (YA1739)DP1 Antibody (YA2766)分子量:503.66Formula:C26H25D7N4O4SCAS 号:1265295-21-3非标记 CAS:475086-01-2性状:固体颜色:White to off-white运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month

CAS:1391012-95-5|Teneligliptin-d8,MP-513 d8

CAS:1391012-95-5|Teneligliptin-d8,MP-513 d8

作者:德尔塔生物 日期:2025-07-08

生物活性:Teneligliptin-d8 is a deuterium labeled Teneligliptin (MP-513). Teneligliptin is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor[1].IC50 & Target:DPP-4Clinical TrialNCT NumberSponsorConditionStart DatePhaseNCT02449330National Cerebral and Cardiovascular CenterDiabetes Mellitus, Type 2June 2015Phase 4NCT02924064Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusSeptember 2016Phase 3NCT02567994Handok Inc.Type 2 Diabetes MellitusApril 2015Phase 3 NCT00628212Mitsubishi Tanabe Pharma CorporationType 2 DiabetesJanuary 2008Phase 2NCT03769870Handok Inc.Diabete MellitusJanuary 11, 2019Phase 1NCT05504239Handok Inc.Type 2 DiabetesOctober 2022Phase 3NCT03793023Handok Inc.Type 2 Diabetes MellitusJanuary 2016NCT04431141Handok Inc.Type 2 Diabetes MellitusSeptember 15, 2020Phase 1NCT02512523Handok Inc.Type 2 Diabetes MellitusAugust 2015Phase 4NCT02314637Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusAugust 2009Phase 3NCT02354222Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusJanuary 2015Phase 3NCT02354235Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusJanuary 2015Phase 3NCT01798238Handok Inc.Type 2 Diabetes MellitusNovember 2012Phase 3NCT00971243Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusAugust 2009Phase 2NCT04446026Yonsei UniversityType 2 Diabetes MellitusJuly 8, 2020Phase 4NCT03011177Handok Inc.Type2 Diabetes MellitusJanuary 2017Phase 4NCT01805830Handok Inc.Type 2 DiabetesMay 2012Phase 3NCT00974090Mitsubishi Tanabe Pharma CorporationType 2 Diabetes MellitusSeptember 2009Phase 3NCT02916706M

CAS:1308278-67-2|Cariprazine-d6,RGH-188-d6

CAS:1308278-67-2|Cariprazine-d6,RGH-188-d6

作者:德尔塔生物 日期:2025-07-08

生物活性:Cariprazine-d6 is a deuterium labeled Cariprazine. Cariprazine Cariprazine is an antipsychotic agent that exhibits high affinity for the D3 (Ki of 0.085 nM) and D2 (Ki of 0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki of 2.6 nM)[1].IC50 & Target[1]:Dopamine D2 Receptor0.49 nM (Ki)Dopamine D3 Receptor0.085 nM (Ki)5-HT1A Receptor2.6 nM (Ki)分子量:433.45Formula:C21H26D6Cl2N4OCAS 号:1308278-67-2非标记 CAS:839712-12-8性状:固体颜色:White to off-white中文名称:卡利拉嗪 d6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month